Global Antiemetics Market is Estimated to Reach $6 Billion by 2024, Says Accurize Market Research
Global Antiemetics Market report published by Accurize Market Research forecast that the global market is expected to reach $6 billion by 2024; growing at a CAGR of 6.6% from 2017 to 2025. By geography, Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.
To browse the complete report, visit at https://www.accurizemarketresearch.com/report/global-antiemetics-market
Rise in number of patients suffering from cancer and increased amount of surgical procedures in the healthcare sector to drive the growth of the market
Rise in number of patients suffering from cancer and increased amount of surgical proceduresfuelthe demand for the global antiemetic’s market.Furthermore,extensive research activities to revolutionize worldwide antiemetic drug therapyalso boost the growth of the market.
The global antiemetics market has been bifurcated on the basis of drug class, application and geography. Drug class segment is further segmented into cannabinoids, benzodiazepines, anticholinergic, steroids and others. Furthermore, application segment includes chemotherapy-induced nausea and vomiting, gastroenteritis, nausea and vomiting of pregnancy (NVP) and post-operative nausea and vomiting. By geography the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Top players in the market
The key players operational in the market includes Abbott Laboratories, AstellasPharma Inc., Aphios Corp., Aurobindo Pharma, Daiichi Sankyo Company Ltd., Eisai Co. Inc., Glaxosmithkline Plc., Helsinn Healthcare Sa, Heron Therapeutics Inc., IPCA Laboratories Ltd., Kyowa Hakko Kirin Pharma Inc., Merck & Co. Inc., Novartis Ag, F. Hoffmann-La Roche Ag, Sanofi Aventis, Tesaro Inc. and Teva Pharmaceutical Industries Ltd., among others.
Head - Sales
Accurize Market Research
K-129, PC COLONY, HANUMAN NAGAR,